NCAM1 and small cell lung carcinoma: In this analysis, we evaluate the potential role of different CT radiomic features and immunohistochemical markers, such as CD56, chromogranin A, synaptophysin, TTF1, Ki 67, CD44, HIF-1a, GLUT-1, PD 1, and PD-L1, in patients with SCLC.